Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Hard to Treat Diseases, Inc. engages in the research, development, purchase, sale and marketing of biological vaccine. Its subsidiaries include Shenzhen Mellow Hope Pharm Industrial Co. Ltd. and Slavica BioChem. The company was founded in 1993 and is headquartered in Clearwater, FL.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
